| Drug Type Small molecule drug | 
| Synonyms 2,8-Diaminoacridine, Proflavine hemisulfate | 
| Target | 
| Action- | 
| Mechanism DNA intercalators | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization- | 
| Active Organization | 
| License Organization- | 
| Drug Highest PhaseClinical | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC13H11N3 | 
| InChIKeyWDVSHHCDHLJJJR-UHFFFAOYSA-N | 
| CAS Registry92-62-6 | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | Proflavine | - | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Esophageal Squamous Cell Carcinoma | Phase 2 | United States  | 31 Jan 2014 | |
| Esophageal Squamous Cell Carcinoma | Phase 2 | China  | 31 Jan 2014 | |
| Adenocarcinoma of Esophagus | Phase 2 | United States  | 30 Sep 2012 | |
| Barrett Esophagus | Phase 2 | United States  | 30 Sep 2012 | |
| Endocarditis, Bacterial | Phase 2 | United States  | 30 Sep 2012 | |
| Carcinoma | Phase 1 | United States  | 25 May 2016 | |
| Muscular Dystrophy, Oculopharyngeal | Phase 1 | United States  | 25 May 2016 | |
| Uterine Cervical Cancer | Phase 1 | United States  | 23 Sep 2015 | |
| Uterine Cervical Dysplasia | Phase 1 | United States  | 23 Sep 2015 | |
| Helicobacter pylori infection | Phase 1 | United States  | 31 Jan 2015 | 
| Not Applicable | 9 | High-Resolution Microendoscopy (HRME) Imaging+Proflavine | aocmyukxay(zktejexsgr) = hsztrnlofz dlzwkrftuy  (jqemmzwtss, bdthagzkjw - lrbbuxxbub) View more | - | 25 Jul 2022 | 





